Earnings Stock to Watch: Ascendis Pharma A/S (NASDAQ: ASND)
Ascendis Pharma A/S (NASDAQ: ASND) net loss widened to 8.28 euros per share for fiscal 2020 from 4.69 euros per share the prior year, which…
Ascendis Pharma A/S (NASDAQ: ASND) net loss widened to 8.28 euros per share for fiscal 2020 from 4.69 euros per share the prior year, which…
Ascendis Pharma A/S (NASDAQ: ASND) stock lost over 1.7% on 28th August, 2020 (as of 9:47 am GMT-4; Source: Google finance) after the company posted…
Ascendis Pharma A/S (NASDAQ: ASND) stock rose over 0.7% on May 20th, 2020 (as of 11:27 am GMT-4; Source: Google finance) after the company posted…
Ascendis Pharma A/S (NASDAQ: ASND) stock fell over 1.1% in the pre-market on April 2nd, 2020 (Source: Google finance) after the company has reported for…
Ascendis Pharma A/S (NASDAQ: ASND) stock rose over 2.8% in the pre market session on November 19th, 2019 (Source: Google finance) after the company in…
Ascendis Pharma A/S (NASDAQ: ASND) stock slightly rose over 0.3% on 29th August, 2019 (As of 11:54 am GMT-4; Source: Google finance) on mixed second…
Ascendis Pharma A/S (NASDAQ: ASND) stock surged 74% on March 4th, 2019 (Source: Google finance) and continued its bullish momentum even on March 5th, 2019….
Ascendis Pharma A/S (NASDAQ: ASND) stock rose over 7% on November 29th, 2018 (as of 10:58 am GMT-5 ; Source: Google finance) after the company announced…